RepliCel Other Operating Expenses vs Reconciled Depreciation Analysis
RP Stock | CAD 0.01 0.01 33.33% |
RepliCel Life financial indicator trend analysis is much more than just breaking down RepliCel Life Sciences prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether RepliCel Life Sciences is a good investment. Please check the relationship between RepliCel Life Other Operating Expenses and its Reconciled Depreciation accounts. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Other Operating Expenses vs Reconciled Depreciation
Other Operating Expenses vs Reconciled Depreciation Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of RepliCel Life Sciences Other Operating Expenses account and Reconciled Depreciation. At this time, the significance of the direction appears to have fragmental relationship.
The correlation between RepliCel Life's Other Operating Expenses and Reconciled Depreciation is 0.57. Overlapping area represents the amount of variation of Other Operating Expenses that can explain the historical movement of Reconciled Depreciation in the same time period over historical financial statements of RepliCel Life Sciences, assuming nothing else is changed. The correlation between historical values of RepliCel Life's Other Operating Expenses and Reconciled Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Other Operating Expenses of RepliCel Life Sciences are associated (or correlated) with its Reconciled Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Reconciled Depreciation has no effect on the direction of Other Operating Expenses i.e., RepliCel Life's Other Operating Expenses and Reconciled Depreciation go up and down completely randomly.
Correlation Coefficient | 0.57 |
Relationship Direction | Positive |
Relationship Strength | Weak |
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of RepliCel Life Sciences. It is also known as RepliCel Life overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Reconciled Depreciation
Most indicators from RepliCel Life's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into RepliCel Life Sciences current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in RepliCel Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At this time, RepliCel Life's Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 5.46 in 2024, whereas Enterprise Value Over EBITDA is likely to drop (3.54) in 2024.
RepliCel Life fundamental ratios Correlations
Click cells to compare fundamentals
RepliCel Life Account Relationship Matchups
High Positive Relationship
High Negative Relationship
RepliCel Life fundamental ratios Accounts
2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
Total Assets | 505.5K | 421.0K | 591.8K | 798.2K | 287.8K | 273.4K | |
Total Current Liabilities | 1.6M | 2.2M | 1.7M | 2.1M | 1.8M | 1.9M | |
Total Stockholder Equity | (4.4M) | (5.1M) | (6.8M) | (5.9M) | (4.5M) | (4.3M) | |
Property Plant And Equipment Net | 6.0K | 4.4K | 3.3K | 2.4K | 967.0 | 918.65 | |
Net Debt | 425.4K | 41.7K | (186.9K) | (372.1K) | 754.0K | 791.7K | |
Retained Earnings | (36.6M) | (38.2M) | (42.2M) | (43.0M) | (43.3M) | (41.1M) | |
Accounts Payable | 640.3K | 1.3M | 602.0K | 817.9K | 416.0K | 472.3K | |
Cash | 23.9K | 34.4K | 221.2K | 413.0K | 59.2K | 56.2K | |
Non Current Assets Total | 272.2K | 235.3K | 198.8K | 162.5K | 125.7K | 119.4K | |
Cash And Short Term Investments | 52.7K | 51.6K | 238.4K | 430.3K | 76.4K | 72.6K | |
Net Receivables | 51.9K | 63.6K | 61.2K | 82.2K | 38.0K | 39.0K | |
Common Stock Shares Outstanding | 24.1M | 27.0M | 32.5M | 37.8M | 59.2M | 62.2M | |
Liabilities And Stockholders Equity | 505.5K | 421.0K | 591.8K | 798.2K | 287.8K | 273.4K | |
Other Stockholder Equity | 4.6M | 4.6M | 5.1M | 5.4M | 5.6M | 5.6M | |
Total Liab | 4.9M | 5.5M | 7.4M | 6.7M | 4.8M | 5.1M | |
Total Current Assets | 233.2K | 185.7K | 393.0K | 635.7K | 162.1K | 154.0K | |
Short Term Debt | 449.3K | 47.3K | 611.4K | 689.3K | 813.2K | 853.8K | |
Common Stock | 27.5M | 28.5M | 30.3M | 31.7M | 33.1M | 20.0M | |
Other Current Liab | 107.3K | 517.8K | 106.6K | 211.8K | 239.5K | 432.0K | |
Other Assets | 266.2K | 230.8K | 195.5K | 1.0 | 1.15 | 1.09 | |
Non Current Liabilities Total | 3.4M | 3.2M | 5.8M | 4.6M | 3.0M | 2.1M | |
Other Current Assets | 128.7K | 70.5K | 93.4K | 123.2K | 47.7K | 89.2K | |
Net Tangible Assets | (1.9M) | (4.4M) | (5.1M) | (6.8M) | (6.2M) | (5.9M) | |
Property Plant Equipment | 8.2K | 6.0K | 4.4K | 3.3K | 2.9K | 2.8K | |
Net Invested Capital | (2.9M) | (5.0M) | (6.8M) | (5.9M) | (5.3M) | (5.6M) | |
Net Working Capital | (1.2M) | (2.1M) | (1.3M) | (1.4M) | (1.3M) | (1.4M) | |
Capital Stock | 29.0M | 28.5M | 30.3M | 31.7M | 36.4M | 32.6M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for RepliCel Stock Analysis
When running RepliCel Life's price analysis, check to measure RepliCel Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy RepliCel Life is operating at the current time. Most of RepliCel Life's value examination focuses on studying past and present price action to predict the probability of RepliCel Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move RepliCel Life's price. Additionally, you may evaluate how the addition of RepliCel Life to your portfolios can decrease your overall portfolio volatility.